Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bionic Technology Restores Amputee Function

By HospiMedica staff writers
Posted on 12 Jan 2007
A range of advanced prosthetic devices has been developed that combines a precise fusion of electronics, mechanics, and human physiology to restore maximum biologic function to amputees.

The new range, called Bionic Technology, aims to identify and utilize new technology that can replace or enhance the functionality of a missing joint or limb. More...
Bionic Technology combines three synergistic technologies that promote advanced and more natural locomotion: sensor technology, artificial intelligence, and actuator technology.

The suite of prostheses includes the Rheo Knee, a microprocessor swing and stance knee system that utilizes artificial intelligence to control magnetorheologic fluid filled actuators that controls its motion; the Power Knee, which works as an integrated extension of its user, synchronizing motion with that of the sound leg; and the Proprio Foot, which combines sensor technology and artificial intelligence to identify sloping gradients and the ascent or descent of stairs after the first step, instructing the ankle to flex appropriately.

These devices work in cooperation with the human body, rather than independently of it, and reduce the physical and mental strain on the amputee while increasing the level of safety of the device. The prostheses adapt to and learn from the user, rather than the other way around.

Bionic Technology was developed by Ossur (Reykjavik, Iceland).

"What drives our highly motivated team is that bionic technology represents a quantum leap forward when it comes to improving the quality of life for amputees,” said Eythor Bender, president of Ossur America.

The Bionic Technology platform and family of products were awarded the Frost & Sullivan (Palo Alto, CA, USA) 2006 award for medical devices technology innovation of the year.



Related Links:
Ossur
Frost & Sullivan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.